| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |